Financials Synchrony Financial

Equities

SYF

US87165B1035

Consumer Lending

Market Closed - Nyse Other stock markets 21:00:02 24/06/2025 BST			5-day change	1st Jan Change
64.74 ^USD	+2.36%		+5.66%	-0.40%

06-24	Synchrony Partners with Sploot Veterinary Care to Finance Comprehensive Veterinary Services with CareCredit	CI
06-24	Seaport Global Adjusts Price Target on Synchrony Financial to $76 From $66, Maintains Buy Rating	MT

Projected Income Statement: Synchrony Financial

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	11,162	10,192	11,674	13,627	16,125	15,188	15,686	16,345
Change	-	-8.69%	14.54%	16.73%	18.33%	-5.81%	3.28%	4.2%
EBITDA	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
EBIT ¹	7,107	6,229	7,337	8,869	11,286	10,254	10,636	11,021
Change	-	-12.35%	17.79%	20.88%	27.25%	-9.15%	3.73%	3.62%
Interest Paid	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	1,797	5,503	3,962	2,904	4,553	3,917	4,037	4,057
Change	-	206.23%	-28%	-26.7%	56.78%	-13.96%	3.05%	0.49%
Net income ¹	1,343	4,179	2,974	2,196	3,427	2,963	3,056	3,108
Change	-	211.17%	-28.83%	-26.16%	56.06%	-13.55%	3.17%	1.69%
Announcement Date	29/01/21	28/01/22	23/01/23	23/01/24	28/01/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	2,718	2,689	2,694	2,581	2,395	2,486	2,730	2,793	2,873	2,915	3,093	3,163	3,294	3,475	3,659	4,798	3,712	3,814	3,801	3,718	3,710	3,848	3,945	3,814	3,802	3,921	4,047
Change	-	-1.07%	0.19%	-4.19%	-7.21%	3.8%	9.81%	2.31%	2.86%	1.46%	6.11%	2.26%	4.14%	5.49%	5.29%	31.13%	-22.63%	2.75%	-0.34%	-2.18%	-0.23%	3.72%	2.53%	-3.33%	-0.31%	3.13%	3.22%
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	1,732	1,711	1,694	1,649	1,447	1,525	1,608	1,754	1,790	1,851	1,942	2,044	2,125	2,321	2,343	3,592	2,535	2,625	2,534	2,475	2,501	2,625	2,702	2,594	2,606	2,670	2,763
Change	-	-1.21%	-0.99%	-2.66%	-12.25%	5.39%	5.44%	9.08%	2.05%	3.41%	4.92%	5.25%	3.96%	9.22%	0.95%	53.31%	-29.43%	3.55%	-3.47%	-2.33%	1.04%	4.96%	2.94%	-3.98%	0.47%	2.46%	3.45%
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	59	412	944	1,315	1,641	1,500	1,047	1,233	1,066	922	741	790	742	833	539	1,708	844	1,028	973	984	842.9	1,065	1,053	1,119	907.8	1,036	954.2
Change	-	598.31%	129.13%	39.3%	24.79%	-8.59%	-30.2%	17.77%	-13.54%	-13.51%	-19.63%	6.61%	-6.08%	12.26%	-35.29%	216.88%	-50.59%	21.8%	-5.35%	1.13%	-14.34%	26.37%	-1.13%	6.24%	-18.86%	14.1%	-7.88%
Net income ¹	37	303	728	1,014	1,232	1,130	803	922	793	692	567	590	559	618	429	1,282	624	768	753	736	638.9	805	774.7	849.4	653.3	762	687.4
Change	-	718.92%	140.26%	39.29%	21.5%	-8.28%	-28.94%	14.82%	-13.99%	-12.74%	-18.06%	4.06%	-5.25%	10.55%	-30.58%	198.83%	-51.33%	23.08%	-1.95%	-2.26%	-13.2%	26%	-3.76%	9.65%	-23.09%	16.64%	-9.79%
Announcement Date	21/07/20	20/10/20	29/01/21	27/04/21	20/07/21	19/10/21	28/01/22	18/04/22	18/07/22	25/10/22	23/01/23	19/04/23	18/07/23	24/10/23	23/01/24	24/04/24	17/07/24	16/10/24	28/01/25	22/04/25	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Synchrony Financial

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	4,251	6,170	3,897	1,723	751	-2,897	-6,922	1,722
Change	-	45.14%	-36.84%	-55.79%	-56.41%	-485.75%	-138.94%	124.88%
Announcement Date	29/01/21	28/01/22	23/01/23	23/01/24	28/01/25	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Synchrony Financial

Fiscal Period:

Estimates

Forecast Financial Ratios: Synchrony Financial

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	-	-	-	-	-	-	-
EBIT Margin (%)	63.67%	61.12%	62.85%	65.08%	69.99%	67.51%	67.8%	67.43%
EBT Margin (%)	16.1%	53.99%	33.94%	21.31%	28.24%	25.79%	25.73%	24.82%
Net margin (%)	12.03%	41%	25.48%	16.12%	21.25%	19.51%	19.49%	19.02%
FCF margin (%)	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	-	-	-	-
Profitability
ROA	1.4%	4.5%	3.1%	2%	2.9%	2.39%	2.37%	2.2%
ROE	11.2%	30.8%	22.6%	16.4%	22.5%	18.26%	17.89%	18.2%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	2.547	12.47	13.85	-	-	-	-	-
Change	-	389.51%	11.05%	-	-	-	-	-
Dividend per Share ¹	0.88	0.88	0.9	0.96	1	1.129	1.221	1.419
Change	-	0%	2.27%	6.67%	4.17%	12.86%	8.16%	16.26%
Book Value Per Share ¹	20.49	24.53	27.7	32.36	39.55	45.05	51.59	53.15
Change	-	19.72%	12.92%	16.82%	22.22%	13.92%	14.5%	3.02%
EPS ¹	2.27	7.34	6.15	5.19	8.55	7.71	8.6	9.541
Change	-	223.35%	-16.21%	-15.61%	64.74%	-9.82%	11.53%	10.95%
Nbr of stocks (in thousands)	583,792	547,259	450,541	413,804	389,344	380,657	380,657	380,657
Announcement Date	29/01/21	28/01/22	23/01/23	23/01/24	28/01/25	-	-	-